Pneumococcal Conjugate Vaccine Breakthrough Infections: 2001–2016

[Figure: see text] BACKGROUND: Most countries use 3-dose pneumococcal conjugate vaccine (PCV) schedules; a 4-dose (3 primary and 1 booster) schedule is licensed for US infants. We evaluated the invasive pneumococcal disease (IPD) breakthrough infection incidence in children receiving 2 vs 3 primary...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Pediatrics
Egile Nagusiak: Adebanjo, Tolulope A., Pondo, Tracy, Yankey, David, Hill, Holly A., Gierke, Ryan, Apostol, Mirasol, Barnes, Meghan, Petit, Susan, Farley, Monica, Harrison, Lee H., Holtzman, Corinne, Baumbach, Joan, Bennett, Nancy, McGuire, Suzanne, Thomas, Ann, Schaffner, William, Beall, Bernard, Whitney, Cynthia G., Pilishvili, Tamara
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: American Academy of Pediatrics 2020
Gaiak:
Articles
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC7055927/
https://ncbi.nlm.nih.gov/pubmed/32054822
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1542/peds.2019-0836
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak